D3 Banking, a leading provider of solutions to replace disparate online and mobile banking products with a single digital banking platform, has promoted Jeff Marshall to chief technology officer. In this role, Marshall will lead the company’s technology strategy, and will be responsible for overseeing data science and innovation.
Marshall has been D3 Banking’s vice president of development for the past 18 months, giving him the opportunity to become fully ingrained into the company’s business and culture. Prior to joining the company, Marshall was vice president of strategic technology at D+H, where he oversaw U.S. product architecture.
“There is a major replacement cycle underway for online and mobile banking systems and D3 Banking is committed to providing the technology innovation and expertise to bring financial institutions to the next level,” said Mark Vipond, CEO of D3 Banking. “Jeff’s deep understanding of fintech and market trends makes him uniquely qualified to guide our technology strategy. His background and proven successes with D3 Banking make him the ideal person to help spearhead further innovation.”
Marshall brings more than 25 years of experience in fintech software architecture and development. No stranger to industry disruptors, Marshall co-founded one of the earlier Internet banking companies, Cavion. The company was sold to Harland Financial Services, and later D+H; Marshall continued his technology leadership roles in each of these companies.
“The time I’ve spent contributing to the technology, culture and mission of D3 Banking has been extremely rewarding to me,” explained Marshall. “I’m excited to be part of an organization that offers a leading, innovative digital banking platform for consumers and small businesses. As CTO, I look forward to working with the team as we explore the possible ways to expand our platform to best meet the evolving needs of our clients and their customers in the digital future.”
Marshall resides in Aurora, Colorado where he is an active member of the community and actively participates in the Muscular Dystrophy Association, a nonprofit focused on curing muscular dystrophy, ALS and related diseases by funding research worldwide.